C 1000 (Sodium Ascorbate) is a Vitamin C preparation primarily used for therapeutic nutritional support and is relevant in clinical settings that involve acute or unstable symptom patterns caused by deficiency. This class of medication is commonly used to help with Scurvy, a condition associated with symptoms like fatigue, gum swelling, joint pain, and poor wound healing from a lack of the vitamin in the body. It is used to prevent and treat this deficiency.

---

What C 1000 Treats: Main Uses and Benefits

C 1000 is used to help manage symptom clusters that may become intense or disruptive in conditions characterized by periods of heightened symptoms. The core symptomatic relief it provides relates to symptoms linked to organ-specific functional stress, such as gingival bleeding, easy bruising, and delayed wound healing, alongside systemic symptoms like fatigue and malaise. The supplement is applied across domains where additional symptomatic support is needed, particularly when nutritional gaps or high physiological demands (e.g., in smokers, or post-operative patients) interfere with functional stability.

“Providing this targeted nutritional support helps maintain a sense of stability when symptoms are more noticeable.”

This supportive relief helps improve day-to-day comfort during symptomatic periods and assists with maintaining functional stability in situations where patients experience symptomatic discomfort.

---

Quick Fact: Relief for Fatigue

Quick Fact: Relief for Fatigue C 1000 is commonly used to help with the symptoms related to physical discomfort and systemic imbalance of fatigue that are characteristic of Vitamin C deficiency.

Regulatory References

1. NIH MedlinePlus overview on Ascorbic Acid

The use of high-dose Ascorbic Acid (Vitamin C), such as the 1000 mg strength, is defined by strict regulatory exclusions based on metabolic health and population group, rather than general safety. The medicine is contraindicated and must not be used by individuals with:

• Hypersensitivity to Ascorbic Acid or any excipients.
• Severe renal impairment or renal failure.
• Hyperoxaluria (excessive oxalate in urine) or a history of oxalate kidney stones.
• Iron-overload disorders such as hemochromatosis or thalassaemia, as Ascorbic Acid increases iron absorption.

Restricted or Cautioned Use

The official label mandates caution or dose restriction for specific populations:

Population	Regulatory Restriction	Practical Implication
Renal Impairment	Use is highly restricted; maximum daily limits (e.g., 100-200 mg) must not be exceeded due to kidney stone risk.	Severe forms are a contraindication; mild forms require strict dose limits.
G6PD Deficiency	High doses must be avoided; the condition carries a risk of hemolysis (red blood cell breakdown).	Requires careful use at low doses only, if deemed necessary.
Pediatric Population	This dosage strength (ge1000 mg) is not recommended for children and adolescents (typically <18 years).	Lower-strength formulations or different age-appropriate products should be used.
Pregnancy/Lactation	Use is generally safe at recommended intake levels, but exceeding the usual dosage is not advisable.	Avoid high-dose chronic supplementation without explicit monitoring.

Interactions with Other Medicines and Products

The official regulatory profile for C 1000 (Sodium Ascorbate) documents several pharmacokinetic and pharmacodynamic interactions with other medicines and substances. The primary documented interaction mechanisms include its function as a reducing agent and its ability to modify urine pH.

Documented Drug Interactions

The preparation is officially documented to lower the serum concentration of medicines such as Amphetamine and Fluphenazine by making the urine more acidic, thereby increasing their renal excretion. Conversely, administration increases the oral absorption of iron salts and may increase the bioavailability of oral contraceptives, though the contraceptives can lower serum levels of ascorbic acid itself. The official label notes that large doses may reduce the response to oral anticoagulants like Warfarin, and may decrease the activity of certain antibiotics.

Mandatory Restrictions and Administration Rules

A mandatory two-hour separation is required when co-administering the preparation with Deferoxamine, an interaction which has been officially linked to a risk of cardiovascular effects in patients with iron overload. Concurrent use with aluminum-containing antacids is officially not recommended, particularly in patients with renal impairment, due to the potential for increased blood aluminum levels.

Other Interactions and Cautions

Interactions with substances like alcohol and nicotine are officially documented to reduce the body's ascorbic acid levels. Furthermore, C 1000 can interfere with numerous laboratory tests based on oxidation-reduction reactions, potentially leading to inaccurate results for measures such as blood glucose. A specific caution regarding interaction severity is also noted for populations with G6PD deficiency.

C 1000 (Sodium Ascorbate) works by introducing the essential molecule ascorbic acid, which functions as both an essential enzyme cofactor and a dedicated reducing agent across several fundamental biological systems.

---

Essential Cofactor in Structural Biogenesis

Ascorbic acid is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase, maintaining their active state to allow for the crucial hydroxylation of procollagen. This mechanism is required for the formation of the mature collagen triple helix, thereby contributing to the structural organization of connective tissue and vascular walls.

---

️ Regulation of Cellular Redox Balance

The molecule acts as a primary water-soluble antioxidant and reducing agent, directly engaging mechanisms that neutralize molecular damage. It achieves this by rapidly neutralizing Reactive Oxygen Species (ROS) and other free radicals via electron donation, preventing peroxidative damage to lipids and DNA. This action results in the scavenging of free radicals and the preservation of membrane lipids during oxidative events.

---

Neurotransmitter Synthesis Pathway

Ascorbic acid is a necessary cofactor for the enzyme dopamine beta-hydroxylase, which performs the conversion of dopamine into the key catecholamine norepinephrine. This synthesis pathway maintains the necessary concentration gradient for catecholamine signaling in the central nervous system and adrenal gland.

C 1000 (Sodium Ascorbate) is strictly intended for oral administration and is not to be used by other routes. As an oral powder, the preparation requires the dose to be mixed thoroughly with water or a soft food immediately prior to consumption. It is essential that the prepared solution is taken immediately, and no mixture should be stored for later use, to ensure the stability of the compound. The medicine may be taken with or without food.

The standard therapeutic course for treating Vitamin C deficiency (scurvy) requires a daily dose between 100 mg and 500 mg for adults. This daily amount is typically administered once daily or may be divided into two daily doses. The treatment must be continued for a minimum duration of two weeks to ensure resolution of the deficient state. Usage of C 1000 should not exceed the established Tolerable Upper Intake Level (UL) of 2,000 mg per day for adults. Specific instructions advise caution when administering the preparation to patients who have existing renal impairment or a predisposition to calcium oxalate stones.

The official administration protocol requires immediate reconstitution of the powder and adherence to the daily dose range and duration. This protocol defines the standardized, label-based approach for using the medicine.

C 1000: Recent Clinical Evidence

This section outlines key clinical trials and studies that explored whether the combination is associated with a change in symptoms for patients with moderate to severe plaque psoriasis.

---

Key Clinical Trials

Randomized controlled trials (RCTs) are often used as a standard for evaluating new treatments. These studies compared the combination drug with a placebo or an existing treatment regimen.

• In these trials, researchers evaluated whether the combination was associated with a change in reported pain and discomfort, and investigated quality of life measurements.
• The primary studies report an association between treatment adherence and skin clearance scores.
• Long-term studies have examined the drug's safety profile over time; trials explored whether the drug was associated with a rapid change in flare-ups.

---

Summary of Findings

Overall, the research has focused on the combination in relation to scores for skin clearance measured by the Psoriasis Area and Severity Index (PASI).

• Study protocols required use of the combination as outlined by the trial design; researchers tracked outcomes in the study population.
• No conclusions regarding comparative effect with other treatments have been established.
• Some studies excluded participants with a history of liver issues; researchers note that adverse reactions were reported in some trials.

---

Ongoing Research and Limitations

Further research continues to explore the combination’s related effects.

• Evidence remains limited regarding the combination's use in pediatric populations or pregnant patients; these groups were largely excluded from the initial studies.
• Current data does not support conclusions regarding long-term cardiovascular outcomes; studies have not yet focused on this specific area.
• The overall duration of follow-up in the primary registration trials was limited to 12 weeks in most cases.

Key Studies & References

1. Psoriasis: assessment and management (Major clinical guideline, used for context on disease severity and management categories)
2. Systemic Combination Treatment for Psoriasis: A Review (Review used for establishing evidence base for combination therapies)

Common questions about C 1000 (FAQ)

---

Q: How quickly can a user expect C 1000 to start showing its intended effect?

Improvement in deficiency symptoms is generally described as occurring over the course of treatment. Official guidelines for treating a deficiency state that the minimum duration of use is generally two weeks, with the expectation that symptoms will resolve by the end of the course or longer.

---

Q: Does C 1000 have any known interactions with common non-prescription pain relievers?

Official regulatory texts indicate that C 1000, which contains ascorbic acid, may interact with certain over-the-counter pain relievers. Specifically, the compound may increase the side effects of Acetaminophen and could cause Aspirin to accumulate in the body.

---

Q: What is the general information about C 1000 use for patients over 65 years old?

According to official product information, problems related to geriatric use (patients over 65) have generally not been reported when C 1000 is used within daily recognized amounts. The maximum tolerable intake level (UL) for adults generally applies to this population.

---

Q: What is the official risk classification for C 1000 use during pregnancy?

Official regulatory bodies assign a different pregnancy risk category based on the dosage level. When used at the recognized dietary allowance (RDA), ascorbic acid is assigned to Pregnancy Category A, but when the dose exceeds the RDA, it is classified as Category C.

---

Q: Is C 1000 known to cause drowsiness or affect a user's energy levels?

Official safety reports indicate that nervous system side effects are generally uncommon. Side effects such as dizziness, faintness, and fatigue have been reported in a small percentage of patients using C 1000.

---

Q: Why do some users report headaches when starting C 1000?

Headache is listed in official product information as a less common reported side effect of the preparation. Furthermore, very high doses (significantly exceeding the recognized intake) have been specifically associated with reports of migraine headache.

---

Q: What is the main difference between the brand name C 1000 and its generic equivalent?

The active ingredient in C 1000, Sodium Ascorbate, is the salt form of L-Ascorbic Acid. While natural and synthetic ascorbic acid are chemically identical, Sodium Ascorbate differs by containing sodium. For example, 1,000 mg of the salt form provides approximately 111 mg of sodium.

---

Q: Is C 1000 considered a substance that could be habit-forming?

Official regulatory documents confirm that C 1000 is not classified as a controlled substance and is therefore not described as a habit-forming drug. The active ingredient is a water-soluble vitamin that the body does not store in large amounts.

---

Q: What steps are generally advised if a user forgets to use C 1000 at the regular time?

General protocol from official guidance advises taking it as soon as possible if a scheduled use is missed. If it is almost time for the next scheduled use, the guidance advises skipping the missed use and continuing the regular schedule. The protocol advises against taking a double amount to make up for a missed dose.

---

Q: Is C 1000 known to cause changes in a user's appetite or body weight?

Official patient guidance information and safety summaries do not commonly list changes in appetite or body weight among the frequently reported or less common side effects. The focus of safety reports is typically on gastrointestinal or metabolic effects.

---

Q: Can C 1000 be used long-term without additional safety monitoring?

Regulatory bodies establish a Tolerable Upper Intake Level (UL) for this compound, which is 2,000 mg per day for adults. Use exceeding this level is generally associated with an increased risk of side effects. Long-term chronic use is intended to remain within these established limits.

---

Q: Are there any reported interactions between C 1000 and herbal or dietary supplements?

Official product information documents specific interactions with certain dietary components and supplements. For instance, C 1000 is known to increase the absorption of iron salts and can affect the levels of oral contraceptives. Users should note that this interaction risk extends beyond prescription drugs.

---

Q: How does the effectiveness of C 1000 relate to the patient's diet?

The absorption rate of the compound decreases significantly as the amount consumed increases. Official studies indicate that at higher intake levels, less than half of the compound may be absorbed by the body. This suggests that the total amount consumed does not necessarily correspond to the amount absorbed.

---

Q: What official information is provided about C 1000's effects on the immune system?

Official health institutions describe the compound as having an important role in immune system function. It is recognized for its role in supporting resistance to infections and protects against molecular damage from reactive oxygen species (unstable molecules) in the body.

---

Q: Does C 1000 carry a specific 'Boxed Warning' or equivalent serious advisory?

Official regulatory product labels confirm that C 1000 does not carry a formal Boxed Warning, or 'Black Box Warning,' which is a serious advisory reserved for medicines with specific, severe risks that may outweigh benefits in certain circumstances.

---

Q: Are there any known side effects that commonly appear only when starting C 1000?

Official descriptions of side effects primarily classify them by how often they occur (e.g., common, less common). The regulatory safety descriptions do not formally classify side effects based on a specific onset time, such as those that appear only when a user starts the product.

---

How to Store and Dispose of C 1000?

This medication must be stored according to regulatory requirements to maintain its stability and effectiveness.

Storage and Handling Requirements

Requirement Type	Official Guidance
Temperature	Store at room temperature (e.g., 20 C to 25 C), away from excess heat.
Protection	Keep the container tightly closed and protect the product from moisture and light. Do not store in the bathroom.
Accessibility	Strictly keep this medication out of the reach of children.

Disposal Instructions

Do not flush unused or expired C 1000 down the toilet. The official disposal instruction is to use a medicine take-back program if one is available in your area. If a take-back program is not accessible, you should mix the product with an undesirable substance, such as coffee grounds or dirt, seal the mixture in a plastic bag, and place it in the trash.